Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1413740
Reference Type
Journal Article
Title
Development of chronic tests for endocrine active chemicals. Part 2: an extended fish early-life stage test with an androgenic chemical in the fathead minnow (Pimephales promelas)
Author(s)
Bogers, R; De Vries-Buitenweg, S; Van Gils, M; Baltussen, E; Hargreaves, A; van de Waart, B; De Roode, D; Legler, J; Murk, A
Year
2006
Is Peer Reviewed?
Yes
Journal
Aquatic Toxicology
ISSN:
0166-445X
EISSN:
1879-1514
Volume
80
Issue
2
Page Numbers
119-130
Language
English
PMID
16989909
DOI
10.1016/j.aquatox.2006.07.020
Web of Science Id
WOS:000242064100003
URL
http:///ac.els-cdn.com/S0166445X06003213/1-s2.0-S0166445X06003213-main.pdf?_tid=a2710cda-d74b-11e5-99a5-00000aacb361&acdnat=1455915735_bfe73f523efeb0787a6bbf858269e32b
Exit
Abstract
The Endocrine Modulators Study Group (EMSG) of the European Chemical Industry has proposed an extended fish early-life stage (ELS) test based on OECD test guideline 210 in combination with a fish pair-breeding reproduction study as a possible alternative for fish full life cycle testing. In this paper the androgen methyldihydrotestosterone (MDHT) was tested in an extended ELS test with fathead minnow supplementary to such a test with the weak estrogen 4-tert-pentylphenol (4TPP). Main endpoints were secondary sexual characteristics (SSC), plasma vitellogenin (VTG) induction and gonadal development. Early blastula embryos were exposed to 0, 0.10, 0.32 and 1.0 microgMDHTl(-1) for up to 114 days post-hatch (dph). A batch of fish exposed to 1.0 microg l(-1) was transferred to clean water after 30 or 63 dph for the remainder of the study. Ethinylestradiol (EE2) was included as estrogenic reference substance at 0.01 microg l(-1). Exposure to MDHT had no significant effect on hatching success or survival, but significantly increased the condition factor of fish exposed for 63 and 114 dph (up to 150% of the control). At 63 dph MDHT exposure induced appearance of tubercles on the snout (a male SSC) of more than 80% of fish. Compared to the controls, plasma VTG was not detectable or significantly lower in fish exposed to MDHT at 0.10 microg/l, but not significantly affected at higher MDHT concentrations. Both lower levels of MDHT significantly inhibited the development of female gonads as of 30 dph. Fish exposed to MDHT at 0.32 and 1.0 microg l(-1) showed higher incidences of mixed sex gonads (10-25%) and smaller testes or dysplasia of gonadal tissue. Dysplasia was present in 80% of the fish continuously exposed to 1.0 microg l(-1) up to 114 dph, but reversible when fish were transferred to dilution water. Results indicate that suppression of ovarian development was the most sensitive endpoint for MDHT exposure after 30 dph. Other endpoints (e.g., growth and SSC) required exposure during at least up to 63 dph to yield a significant effect. Androgenic effects on VTG production required even longer exposure, i.e., until sufficient number of females had matured.
Keywords
methyldihydrostestosterone; sexual differentiation; gonad histology; medaka oryzias-latipes; zebrafish danio-rerio; secondary sex; characteristics; mill effluent; in-vivo; nonaromatizable androgens; receptor agonist; methyltestosterone; disruption; Marine & Freshwater Biology; Toxicology; 0 (Androgens); 0 (Vitellogenins); 08J2K08A3Y (Dihydrotestosterone); 423D2T571U (Ethinyl Estradiol); Androgens/ toxicity; Animals; Behavior, Animal/drug effects; Cyprinidae/embryology/growth & development/ physiology; Dihydrotestosterone/ analogs & derivatives/analysis/ toxicity; Embryo, Nonmammalian/ drug effects; Ethinyl Estradiol/analysis/toxicity; Gonads/drug effects; Sex Characteristics; Sex Ratio; Survival Analysis; Time Factors; Toxicity Tests/ methods; Vitellogenins/blood/drug effects
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity